New specialist European and US life sciences investors join existing investors to enable Nouscom to continue advancing the clinical development of [...]
Onera Health, a leader in sleep diagnostic and monitoring solutions, closed a €30M ($32M) Series C financing round. The all-equity round was led by EQT Life Sciences and co-led by Gimv, with existing investors Innov [...]
Phagenesis, a medical devices company, which specializes in the treatment of swallowing disorders, successfully closes a $42M Series D financing round led by EQT Life Sciences and co-led by Sectoral Asset Management [...]
Phagenesis, a medical devices company, which specializes in the treatment of swallowing disorders, successfully closes a $42M Series D financing round led by EQT Life Sciences and co-led by Sectoral Asset Management[...]
Onera Health, a leader in sleep diagnostic and monitoring solutions, closed a €30M ($32M) Series C financing round. The all-equity round was led by EQT Life Sciences and co-led by Gimv, with existing investors Innov[...]
Round co-led by EQT Life Sciences and Forbion
Series A financing will support clinical development of the lead program in amyotrophic lateral sclerosis (ALS) and preclinical development of pip[...]
New specialist European and US life sciences investors join existing investors to enable Nouscom to continue advancing the clinical development of its portfolio of neoantigen cancer vaccines to key clinical proof of c[...]
Amsterdam, The Netherlands, October 16, 2023 - EQT Life Sciences is happy to announce an investment from the LSP Dementia Fund into AstronauTx Ltd. (“AstronauTx” or “the Company”), a UK based biotech compan[...]
EQT Life Sciences leads investment in MinervaX with OrbiMed also joining as a new investor
The financing will advance the development of MinervaX’s maternal vaccine against Group B Streptococcus and he[...]
- EQT Life Sciences invests together with other new investors Fidelity Management & Research Company, Canaan and Dawn Biopharma, a platform controlled by KKR
- Proceeds will support [...]
The LSP Dementia Fund has held its final close at approximately EUR 260 million, at the hard cap and above its original target fund size of EUR 100 million
Investors include the Alzheimer’s Association, th[...]
Proceeds will advance a pipeline of precision medicines against neurodegenerative diseases.
Funding will support the clinical development of two therapeutic product candidates for ALS.
AMSTERDAM[...]
Onera Health, a leader in sleep diagnostic and monitoring solutions, closed a €30M ($32M) Series C financing round. The all-equity round was led by EQT Life Sciences and co-led by Gimv, with existing investors Innov [...]
Phagenesis, a medical devices company, which specializes in the treatment of swallowing disorders, successfully closes a $42M Series D financing round led by EQT Life Sciences and co-led by Sectoral Asset Management [...]